Comac Medical is delighted to announce our participation in BioEquity Europe 2025, taking place from 12–14 May at the Bruges Meeting & Convention Centre (BMCC) in Bruges, Belgium. Celebrating its 25th year, BioEquity Europe stands as a premier event for biopharma executives and financial dealmakers to connect with emerging biotech companies. 

Representing Comac Medical at this conference are Diana Gheorghi, BD Director and Biljana Stuperavic, BD Manager who are eager to engage with industry leaders, investors, and innovators to explore collaborative opportunities and discuss the evolving landscape of biotech investments. 

The conference will feature over 100 biotech companies, curated by BioCentury, offering insights into cutting-edge research and development. Attendees will benefit from a busy and interesting schedule, including panel discussions, and partnering meetings, all designed to foster meaningful connections and strategic partnerships.  

Comac Medical is committed to advancing clinical research and fostering innovation in the biotech sector. Our presence at BioEquity Europe 2025 underscores our dedication to collaborating with partners who share our vision for improving patient outcomes through scientific excellence.

Connect with Us in Advance

We invite you to meet with Diana Gheorghi and Biljana Stuperavic during the event to discuss potential collaborations and learn more about Comac Medical’s services and therapeutic expertise in supporting your next pharma or biotech venture.